ZEBRAFISH DISEASE MODELS SOCIETY (EIN 471140026) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

MARINA MIONE

Phone

5183997181

Tax Period

2024-01-01 to 2024-12-31

ZEBRAFISH DISEASE MODELS SOCIETY, founded in 2014, is a small nonprofit in the Medical Research sector that reported $255K in total revenue in fiscal year 2024. Revenue surged 31% from the prior year, signaling strong growth momentum. The organization ran a surplus of $48K, a strong 19% operating margin.

Mission

TO PROMOTE THE ADVANCEMENT OF BASIC & CLINICAL RESEARCH THROUGHOUT THE WORLD USING THE ZEBRAFISH DISEASE MODELS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $13,500

Program Service Revenue $241,386

Investment Income $38

Other Revenue $0

TOTAL REVENUE $254,924

Expense Breakdown

Grants Paid $3,446

Salaries & Benefits $0

Fundraising Expenses $359

Program Expenses $164,246

Other Expenses $203,416

TOTAL EXPENSES $206,862

Year-over-Year Comparison

	2024	2023	Change
Revenue	$254,924	$194,218	+0.3%
Expenses	$206,862	$238,609	-0.1%
Net Income	$48,062	$-44,391	-2.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MARINA MIONE	PRESIDENT	5.00	Officer Director	$0	$0	$0
TERESA BOWMAN	VICE PRESIDENT	5.00	Officer Director	$0	$0	$0
ANNEMARIE MEIJER	SECRETARY	5.00	Officer Director	$0	$0	$0
TRISTA NORTH	TREASURER	5.00	Officer Director	$0	$0	$0
KAZUHIDE ASAKAWA	DIRECTOR (THRU OCT)	1.00	Director	$0	$0	$0
BON-CHU CHUNG	DIRECTOR	1.00	Director	$0	$0	$0
ANDREW COX	DIRECTOR	1.00	Director	$0	$0	$0
HUI FENG	DIRECTOR	1.00	Director	$0	$0	$0
YI FENG	DIRECTOR	1.00	Director	$0	$0	$0
RITA FIOR	DIRECTOR	1.00	Director	$0	$0	$0
MIGUEL GODHINO	DIRECTOR	1.00	Director	$0	$0	$0
MARY GOLL	DIRECTOR	1.00	Director	$0	$0	$0
CHRIS HALL	DIRECTOR	1.00	Director	$0	$0	$0
GENEVIEVE KENDALL	DIRECTOR	1.00	Director	$0	$0	$0
SOFIA DE OLIVEIRA	DIRECTOR	1.00	Director	$0	$0	$0
CARINE SMITH	DIRECTOR	1.00	Director	$0	$0	$0
DAVID TOBIN	DIRECTOR	1.00	Director	$0	$0	$0
EIRINI TROMPOUKI	DIRECTOR	1.00	Director	$0	$0	$0
VALERIE WITTAMER	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$254,924	$206,862	$254,379	$48,062
2023	$194,218	$238,609	$204,561	$-44,391
2022	$213,629	$247,938	$244,609	$-34,309
2020	$29,591	$74,343	$262,570	$-44,752
2019	$282,760	$200,232	$310,174	$82,528
2018	$278,891	$215,803	$240,147	$63,088

ZEBRAFISH DISEASE MODELS SOCIETY